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Abstract: Mesenchymal stem cells (MSCs) could be useful for regenerative medicine because they can be 
harvested easily from the bone marrow of living donors and the cells can be differentiated into adipogenic, 
osteogenic, and chondrogenic lineages in vitro. To apply MSCs for the medical treatment of human diseases as 
regenerative medicine, detailed experimental characterization of the cells is required. Recently, a New World 
primate, the common marmoset (Callithrix jacchus), has been widely used as a new human disease model be-
cause of its ease of handling and breeding. Although common marmoset MSCs have been established and will 
be used in preclinical studies of regenerative medicine, the characteristics of these cells remain unclear. Aiming 
to characterize common marmoset MSCs further, we harvested common marmoset bone marrow-derived cells 
(cmBMDCs) from the femurs of newborn males. We revealed that the morphology of the cells was similar 
to common marmoset fibroblasts, and extracellular matrix components, such as gelatin and fibronectin, were 
effective for their proliferation and formation of colony-forming unit fibroblasts. Furthermore, we were able 
to differentiate cmBMDCs into adipocytes, osteocytes, and chondrocytes in vitro, and they expressed the MSC 
markers CD44, CD73, CD90, and CD105, but their expression decreased with increasing passage number. The 
data demonstrate that cmBMDCs exhibit characteristics of MSCs and thus it would be beneficial to use these 
cells in preclinical studies. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 4, 292–299)
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Introduction
Stem cells are essential to regenerative medicine 
because of their ability to differentiate into a wide 
variety of cell types. Mesenchymal stem cells (MSCs), 
which are derived from bone marrow, are one of the 
many kinds of stem cells and are known as multipo-
tent stem cells that have the potency to differentiate 
into mesoderm-derived lineages, such as adipocytes, 
osteocytes, and chondrocytes [1, 2]. MSCs are also 
easy to handle and are relatively safe for use in rege-
nerative medicine because the method used to isolate 
them from human bone marrow has been established 
and the cells pose no risk for immune rejection. In 
addition, the development of tumors in patients who 
receive implanted MSCs has not been reported yet 
[3]. Recently, although induced pluripotent stem (iPS) 
cells have been established from human somatic cells 
and also do not induce an immune response, these 
cells have the ability to form tumors in vivo [4]. Due to 
these advantages of MSCs, they could be used widely 
in regenerative medicine. 
MSCs have been well characterized in humans 
and mice [5, 6]. For example, MSCs have a similar 
morphology to fibroblasts, they have the ability to 
form colony-forming unit fibroblasts (CFU-F), and 
they express surface markers such as CD29, CD44, 
and CD90, but not the hematopoietic and endothelial 
markers CD34 and CD45 [6, 7]. Despite the stem cell 
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characteristics of MSCs, these cells can undergo only 
a limited number of cell divisions, which is a limitation 
for their use in regenerative medicine. With an aim 
to resolve this major problem, immortalized human 
MSCs have been established; however, these cells 
gained the ability to form teratomas [8].
The common marmoset (Callithrix jacchus) is 
a New World non-human primate species and is an 
important experimental animal to elucidate the me-
chanisms underlying human diseases and to develop 
effective therapies [9]. This primate is relatively easy 
to use in a wide range of research fields in comparison 
with other experimental models because of its small 
body size (adult size: 200–500 g), attaining sexual 
maturity at the age of 1 year, and high breeding effi-
ciency. Actually, a spinal cord injury model has been 
developed with an aim to find cures for serious dise-
ases [10]. Recently, embryonic stem cells and iPS cells 
were established from the common marmoset and, in 
addition, transgenic common marmosets expressing 
enhanced green fluorescent protein (EGFP) have 
been generated [11–13]. Thus, these cells and trans-
genic marmosets will provide important tools for use 
in preclinical studies. 
MSCs have been established from rhesus ma-
caques, cynomolguses, and common marmosets 
[14–16]. All of these cells have the ability to diffe-
rentiate into three lineages: adipocytes, osteocytes, 
and chondrocytes. However, the characteristics of 
common marmoset MSCs are not well understood. 
Given this background, we harvested and characte-
rized common marmoset bone marrow-derived cells 
(cmBMDCs). 
Material and methods
Animals. We used common marmosets obtained from 
CLEA Japan (EDM: C. Marmoset (Jic); CLEA Japan, 
Tokyo, Japan) at the Animal Facility of the Natural Science 
Center for Basic Research and Development, Hiroshima 
University, and maintained the animals at the Central Insti-
tute for Experimental Animals. All experiments were carried 
out after obtaining permission from the Institutional Animal 
Care and Use Committee of Animal Experimentation at 
Hiroshima University.
Harvesting and culture of cmBMDCs and fibroblasts. To 
harvest cmBMDCs, both epiphyses of the femurs from 
newborn common marmoset males were cut off and then 
flushed out using a syringe (23-gauge needle) containing 
M2 medium (Sigma, St. Louis, MO, USA). The extracted 
cells were seeded in culture dishes and washed using Dul-
becco’s modified Eagle’s medium (DMEM; Wako, Osaka, 
Japan) containing 10% fetal bovine serum (FBS; Invitrogen, 
Carlsbad, CA, USA) and 100 U/mL penicillin-streptomycin 
(Nacalai Tesque, Kyoto, Japan) to remove floating cells. The 
adherent cells were expanded in DMEM with 10% FBS and 
100 U/mL penicillin-streptomycin at 37°C in 5% CO2. When 
the cells were ~70% confluent, they were dissociated with 
0.25% trypsin (Invitrogen) and passaged in 100-mm dishes. 
To harvest common marmoset fibroblasts, the ears of 
newborn males were minced with scissors and cultured in 
35-mm culture dishes containing DMEM with 10% FBS 
and 100 U/mL penicillin-streptomycin at 37°C in 5% CO2. 
The cells were dissociated with 0.25% trypsin/EDTA before 
they reached 100% confluence.
Proliferation assay. To investigate the effect of extracellular 
matrix coatings on the proliferation of cmBMDCs, a total of 
1,500 cells were seeded in uncoated, 0.1% gelatin- (Millipo-
re, Temecula, CA, USA), collagen type I-C- (Nitta Gelatin, 
Tokyo, Japan), and fibronectin-coated (BD Biosciences, 
Franklin Lakes, NJ) 12-well plates, and trypsinized cells 
were collected and counted with a counting chamber every 
3 days (n = 4). This experiment was performed over a period 
of 8 days. In addition, to examine the effect of the coatings 
on the proliferation of the cells over a longer period, we 
measured population doubling levels (PDLs). We seeded 
10,000 cells in uncoated, gelatin-, collagen-, and fibronectin-
coated 12-well plates, and trypsinized cells were collected 
and counted every 4 days (n = 3). PDLs were calculated 
using the following formula: PDL = log2 (collected cell 
number / seeded cell number).
In vitro differentiation assay. Adipogenic, osteogenic, and 
chondrogenic differentiation were induced using the Human 
Mesenchymal Stem Cell Functional Identification Kit (R&D 
Systems, Minneapolis, MN, USA) according to the manufac-
turer’s instructions. Briefly, for adipogenic differentiation, the 
cells were seeded at a density of 2.1 × 104 cells/cm2. When the 
cells were 100% confluent, they were cultured in adipogenic 
differentiation medium for 2 weeks. Adipocytes were stained 
with Oil Red O (Sigma). For osteogenic differentiation, the 
cells were seeded at a density of 4.2 × 103 cells/cm2. The next 
day, when the cells were ~70% confluent, they were cultured 
in osteogenic differentiation medium for 2 weeks. Osteocytes 
were stained with Alizarin Red S (Sigma). For chondrogenic 
differentiation, 5.0 × 105 cells were seeded in a 15-mL conical 
tube containing chondrogenic differentiation medium. After 
3 weeks, the chondrocytes were fixed with 4% paraformal-
dehyde (PFA; Sigma), embedded in paraffin, sectioned, and 
stained with Toluidine Blue (Sigma).
Colony-forming unit fibroblast assay. To form colonies, 
100 cells were seeded in uncoated, gelatin-, collagen-, and 
fibronectin-coated 100-mm dishes for 2 weeks. After fixing 
the colonies with 4% PFA, they were stained with 10% 
Giemsa (Merck, Darmstadt, Germany). Colonies that were 
more than 3 mm in diameter were counted as propagated 
cell colonies.
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Immunofluorescence staining. The cells were cultured on 
4-well chamber slides coated with 0.1% gelatin and then fixed 
with 4% PFA for 30 min, rinsed in phosphate-buffered saline 
(PBS), and treated with Protein Block, Serum-Free (DAKO, 
Carpentaria, CA, USA) for 30 min. Anti-CD34 (AbD Sero-
tec, Kidlington, UK), anti-CD44 (Thermo Fisher Scientific, 
Fremont, CA, USA), anti-CD73 (Acris Antibodies, Herford, 
Germany), anti-CD90 (BioLegend, San Diego, CA, USA), 
and anti-CD105 (GeneTex, Irvine, CA) antibodies were 
used as primary antibodies. The cells were incubated with 
the antibodies diluted in Background Reducing Solution 
(DAKO) for 1 h. After the cells were washed in PBS, they 
were incubated with Alexa Fluor 568 goat anti-rabbit IgG and 
Alexa Fluor 488 goat anti-mouse IgG secondary antibodies 
(Molecular Probes, Eugene, OR, USA) for 1 h. The cells 
were mounted on glass slides with VECTASHIELD (Vector 
Laboratories, Burlingame, CA, USA) and observed under a 
fluorescent microscope (BZ-9000; Keyence, Osaka, Japan). 
All procedures were performed at room temperature.
Western blotting. To extract proteins from the cells, we 
used RIPA Buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 
1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, 
1 mM EDTA, pH 8.0) containing protease inhibitor and 
phosSTOP inhibitor cocktails (Roche Diagnostics GmbH, 
Mannheim, Germany). The whole cell extracts were centri-
fuged at 20,879 × g for 20 min at 4°C to gain cell lysates. The 
lysates (20 μg) were separated by 8 or 10% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and transferred 
to an Immobilon-P membrane (Millipore). The membrane 
was blocked with 5% skim milk (Nacalai) in Tris-buffered 
saline/Tween-20 (TBST) at room temperature for 1 h and 
then incubated with primary antibodies diluted in 5% skim 
milk at 4°C overnight. The membranes were washed with 
TBST and then incubated with secondary antibodies at 
room temperature for 1 h. After washing with TBST, the 
signals were detected using ECL Western blotting detection 
reagents or the ECL Plus Western Blotting Detection Sys-
tem (GE Healthcare, Piscataway, NJ, USA). The primary 
antibodies used were: anti-CD34 (AbD Serotec), anti-CD44 
(Thermo), anti-CD73 (Acris Antibodies), anti-CD90 (Biole-
gend), anti-CD105 (GeneTex), and anti-GAPDH (Sigma). 
The secondary antibodies used were: anti-rabbit and anti
-mouse HRP conjugate (GE Healthcare).
Quantitative real-time PCR. Total RNA was isolated 
using an RNeasy Mini Kit (QIAGEN, Valencia, CA, 
USA), and then 1 μg of total RNA was reverse transcribed 
using ReverTra Ace (Toyobo, Osaka, Japan). Quantita-
tive real-time PCR (qPCR) was performed with SYBR 
premix Ex Taq-II (Takara, Kyoto, Japan) according to 
the manufacturer’s instructions. The expression levels of 
endogenous mRNA (CD44 and CD90) were measured 
with the Mx3000P QPCR system (Agilent Technologies, 
La Jolla, CA, USA). Primer sequences were as follows: 
GAPDH, 5’-CATCCCTGAGACACCATGGGGAAG-3’ 
and 5’-GGGATCATTGATGGCGATGACATCC-3’; 
CD44, 5’-GCAAGGCTTTCAATAGCACCTTGC-3’and 
5’-GTTGGGGTGGATCCGAGGAATCAC-3’; and 
CD90, 5’-CTGGACTGAGCTTCCAGAACCATGA-3’ 
and 5’-GTATTCTCATGGCGGCAGTCCAGAC-3’. The 
relative expression levels were normalized against GAPDH.
Statistical assessment. The data for CFU-F efficiency were 
analyzed using the chi-square test with P < 0.05 considered 
significant.
Results
Analysis of the morphology and proliferation  
of cmBMDCs
In a previous report, MSCs exhibited a fibroblast-like 
morphology [14]; therefore, we harvested cmBMDCs 
from the femur of newborn common marmoset males 
and performed morphological analysis of the isolated 
cells. The cells were spindle-shaped and similar to 
common marmoset fibroblasts (Figure 1A). Next, 
to investigate the effect of the extracellular matrix 
components gelatin, collagen, and fibronectin on the 
proliferation of cmBMDCs, we seeded the cells on 
matrix-coated plates and counted the cells every 3 days 
for up to 8 days. However, differences in the effects 
of these coating on proliferation were not clear in 
this short period (Figure 1B). In order to clarify their 
effects, we plotted the PDLs from passage 6 (P6) to 
P13. The results show that the proliferation activity 
of the three extracellular matrices was higher than for 
uncoated plates; especially, gelatin and collagen were 
the most effective (Figure 1C).
cmBMDCs differentiate into adipocytes, osteocytes, 
and chondrocytes in vitro
MSCs can be differentiated into three lineages: adipo-
cytes, osteocytes, and chondrocytes. To examine the 
differentiation ability of our established cmBMDCs, 
the cells were cultured in the relevant differentiation 
medium. After 2 weeks in adipogenic differentiation 
medium, small lipid vesicles were visualized and 
stained with Oil Red O (Figure 2A and 2B). After 
culturing cmBMDCs in osteogenic differentiation 
medium for 2 weeks, the cells were positively stained 
with Alizarin Red S (Figure 2C). After culturing the 
cells in chondrogenic differentiation medium for 
3 weeks, we observed a spherical-shaped pellet and 
sections of this pellet were stained with Toluidine Blue 
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(Figure 2D and 2E). These results indicate that the 
cmBMDCs share common characteristics with MSCs 
such as their ability to differentiate into adipocytes, 
osteocytes, and chondrocytes in vitro.
Gelatin and fibronectin enhance the ability 
of cmBMDCs to form CFU-F 
MSCs also have the ability to form CFU-F [15, 17]; 
therefore, we investigated whether cmBMDCs also 
have this ability. We found that the cells were able 
to form cell colonies of various sizes (Figure 3A). 
To seek the most appropriate extracellular matrix 
condition to form colonies, we seeded the cells on 
uncoated, gelatin-, collagen-, and fibronectin-coated 
dishes, and counted the number of colonies with 
a diameter of more than 3 mm. The results showed that 
the number of colonies was significantly increased on 
gelatin- and fibronectin-coated dishes compared with 
the uncoated dishes (P < 0.05), but not collagen-co-
ated dishes (Figure 3B). Taking these results together 
with those from the cell proliferation assay (Figure 1B 
FibroblastscdBMDCsA
B C
Figure 1. Analysis of morphology and proliferation. A. Comparison of the morphology of common marmoset bone mar-
row-derived cells (cmBMDCs) and ear-derived fibroblasts. White scale bar: 100 μm. B. Proliferation assay of cmBMDCs. 
The cells were seeded on uncoated, gelatin-, collagen-, and fibronectin-coated 12-well plates, and trypsinized cells were 
collected and counted every 3 days (n = 4). C. Determination of the population doubling level. The cells were seeded on 
uncoated, gelatin-, collagen-, and fibronectin-coated 12-well plates, and trypsinized cells were collected and counted every 
4 days (n = 3)
and 1C), gelatin and fibronectin effectively induce 
these abilities in cmBMDCs, but collagen was not 
suitable for the induction of CFU-F activity. 
cmBMDCs express MSC markers 
Human and non-human primate MSCs express cell 
surface proteins such as CD44, CD73, CD90, and 
CD105, but not the hematopoietic- and endothelial
-specific proteins CD34 and CD45 [7, 15]. To examine 
whether cmBMDCs express these proteins, we per-
formed immunofluorescence staining using the cells 
at P10 and P20. We found that cmBMDCs strongly 
expressed CD44 and CD90, and slightly expressed 
CD73 and CD105, but faintly expressed CD34, which 
is negative marker for MSCs (Figure 4A). By contrast, 
since the fibroblasts expressed CD90 at a very low 
level, it is speculated that this protein is a positive 
marker for cmBMDCs. Although we compared the 
expression of these proteins in cmBMDCs between 
P10 and P20, there were no apparent differences in 
their expression. Aiming to clarify the differences, 
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Figure 2. In vitro differentiation of cmBMDCs. Adipogenic differentiation was induced using adipogenic differentiation 
medium. A. Morphology of adipocytes. B. Adipocytes were stained with Oil Red O. C. Osteocytes induced using osteoge-
nic differentiation medium were stained with Alizarin Red S. Chondrogenic differentiation was induced using chondro-
genic differentiation medium. D. Morphology of chondrocytes. E. Chondrocytes were stained with Toluidine Blue. White 
scale bar: 100 μm
A B
Uncoated Gelatin Collagen Fibronectin
C
Figure 3. Colony-forming unit fibroblast assay of cmBMDCs. A. Giemsa-stained colonies cultured on an uncoated dish.  
B. The graph shows the quantification of the number of stained colonies ≥ 3 mm in diameter. The number of colonies was 
significantly increased by gelatin and fibronectin (*P < 0.05), but not by collagen, compared to cells cultured on uncoated 
dishes (n = 4). The data are represented as mean ± SEM (n = 4). *P < 0.05. C. The figure shows Giemsa-stained colo-
nies cultured on uncoated, gelatin-, collagen-, and fibronectin-coated dishes
the expression levels of these proteins were evaluated 
using Western blotting. In cmBMDCs, the expression 
of CD44, CD73, CD90, and CD105 was decreased by 
P20. Conversely, the expression of these proteins was 
lower in fibroblasts at P10 than in cmBMDCs at P10 
(Figure 4B). This suggests that the expression of these 
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cell surface proteins tends to decrease with increasing 
passage number. However, on the contrary, CD34 was 
barely expressed in cmBMDCs at P10 and was slightly 
increased in cmBMDCs at P20 (Figure 4B). 
To verify the results of the Western blotting analy-
sis, we compared the expression levels of CD44 and 
CD90 mRNA at P10 and P20 by qPCR analysis. As 
Fibroblasts P12cmBMDCs P10 cmBMDCs P20
A
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20
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las
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P1
2
CD44
CD73
CD90
CD105
CD34
GAPDH
C
B Figure 4. Expression of cell surface markers in cmBMDCs 
and fibroblasts. A. Immunofluorescence staining of cmB-
MDCs and fibroblasts. The cells were stained to visualize 
CD44, CD90, CD105, CD34 (green), and CD73 (red). The 
nuclei were counterstained with DAPI (blue). White scale 
bar: 100 μm. B. Western blotting analysis of CD34, CD44, 
CD73, CD90, CD105, and GAPDH (B). C. qPCR analysis 
of CD44 and CD90 mRNA. Levels of mRNA are normali-
zed to GAPDH
a result, there was no significant change in the expres-
sion of each mRNA with increasing passage number 
(Figure 4C), suggesting the data are not consist with 
those from Western blotting analysis.
Discussion
MSCs are very attractive multipotent stem cells becau-
se of their ability for self-renewal and multi-lineage 
differentiation, and they are also easy to harvest from 
bone marrow. Recently, common marmosets have 
been noted as a new non-human primate model of 
human diseases, and have been used to assess prec-
linical cell therapy and stem cell therapy, including 
gene targeting, to elucidate how to treat intractable 
diseases [18–21]. Common marmoset MSCs would 
also be useful stem cells in preclinical studies; there-
fore, the characterization of these cells is essential to 
develop the research field of regenerative medicine.
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body size. Previously, a perfusion method to collect 
MSCs from the ilium of living cynomolgus monkeys 
using PBS was reported [26]. In the future, we plan 
to investigate whether this method can also be used 
to collect cmBMDCs. As an additional improvement 
after collecting cmBMDCs, eliminating contamina-
ting fibroblasts from the bone marrow is important. 
In humans, to avoid this contamination, a cell sorting 
system using a combination of human MSC- and 
fibroblast-positive antibodies was developed [27]. 
However, given the similarities in the properties of 
MSCs and fibroblasts, complete separation of these 
cells is difficult; hence, it is important to identify 
cmBMDC- or fibroblast-positive antibodies to di-
stinguish between these cells. Our data suggest that 
CD90 has the potential to be a candidate protein to 
distinguish between these cells because its expression 
was markedly different in cmBMDCs and fibroblasts. 
We also intend to investigate whether cmBMDCs 
maintain MSC characteristics beyond P20, such as 
self-renewal, proliferation activity, and cell surface 
protein expression.
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